# Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)

> **NCT00660764** · — · COMPLETED · sponsor: **AstraZeneca**

## Conditions studied

- Hypercholesterolemia
- Coronary Heart Disease
- Peripheral Vascular Disease
- Cerebrovascular Accident
- Diabetes

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT00660764
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** — (—)
- **Last updated:** 2009-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00660764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00660764, "Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00660764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*